CIK 0001559053
- Accelerated filer
PROTHENA CORP PUBLIC LTD CO
Sign in to watch- Ticker
- PRTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- Operating
- Phone
- +353 12362500
- Business address
- 77 SIR JOHN ROGERSON'S QUAY, BLOCK C, GRAND CANAL DOCKLANDS, DUBLIN 2, Ireland, D02 VK60
- Former names
- Prothena Corp plc, Neotope Corp Ltd
- Open-market buys, last 90 days
- $9,848,721
- in 10 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,848,721. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-22 | Zago Wagner M. Chief Scientific Officer | Option exercise | +81,250 | $15.04 | $1.2M | 115,250 |
| 2021-06-22 | Zago Wagner M. Chief Scientific Officer | Sale | −65,840 | $45.42 | $3.0M | 49,410 |
| 2021-06-22 | Zago Wagner M. Chief Scientific Officer | Sale | −26,106 | $46.27 | $1.2M | 23,304 |
| 2021-06-22 | Zago Wagner M. Chief Scientific Officer | Sale | −18,101 | $47.81 | $865K | 5,203 |
| 2021-06-22 | Zago Wagner M. Chief Scientific Officer | Sale | −5,203 | $49.01 | $255K | 0 |
| 2021-06-22 | Zago Wagner M. Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −15,000 | 0 | ||
| 2021-06-22 | Zago Wagner M. Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −19,000 | 0 | ||
| 2021-06-22 | Zago Wagner M. Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −81,250 | 68,750 | ||
| 2021-06-18 | EcoR1 Capital, LLC 10% owner | Option exercise | +250,000 | $30.00 | $7.5M | 11,284,280 |
| 2021-06-18 | EcoR1 Capital, LLC 10% owner | Option exercise · Call Option (Right to Purchase) | −2,500 | 0 | ||
| 2021-05-19 | Cooke Shane Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2021-05-19 | Patel Sanjiv Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2021-05-19 | COLLIER RICHARD T Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2021-05-19 | Cobb Paula K Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2021-05-19 | Ekman Lars Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2021-05-19 | Selkoe Dennis J. Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2021-05-19 | HENNEY CHRISTOPHER S Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2021-05-19 | Harfstrand Karl Anders Olof Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2021-04-05 | Garren Hideki Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2021-03-24 | EcoR1 Capital, LLC 10% owner | Purchase | +875,000 | $20.75 | $18.2M | 11,034,280 |
Page 34 of 41 · 819 trades